1,3,2-Dioxaphosphorinane, 5-butyl-5-ethyl-2-[2,4,6-tris(1,1-dimethylethyl)phenoxy]-

Catalog No. :
ACLDSG527
CAS No. :
161717-32-4
Molecular Formula :
C27H47O3P
Molecular Weight :
450.64

IUPAC Name:5-butyl-5-ethyl-2-(2,4,6-tri-tert-butylphenoxy)-1,3,2-dioxaphosphinane

1,3,2-Dioxaphosphorinane, 5-butyl-5-ethyl-2-[2,4,6-tris(1,1-dimethylethyl)phenoxy]- structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$450.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3,2-Dioxaphosphorinane, 5-butyl-5-ethyl-2-[2,4,6-tris(1,1-dimethylethyl)phenoxy]-
IUPAC Name5-butyl-5-ethyl-2-(2,4,6-tri-tert-butylphenoxy)-1,3,2-dioxaphosphinane
Molecular FormulaC27H47O3P
Molecular Weight450.64
SMILESCC(C1=C(OP2OCC(CC)(CCCC)CO2)C(C(C)(C)C)=CC(C(C)(C)C)=C1)(C)C
InChI KeyHVDJXXVDNDLBQY-UHFFFAOYSA-N
Synonym1,3,2-Dioxaphosphorinane, 5-butyl-5-ethyl-2-[2,4,6-tris(1,1-dimethylethyl)phenoxy]-;2,4,6-TRIS(TERT-BUTYL)PHENYL-2-BUTYL-2-ETHYL-1,3-PROPANEDIOLPHOSPHITE;ULTRANOXXR2677;2,4,6-TRI-TERT-BUTYLPHENYLCYCLICPHOSPHITEOFBUTYLETHYLPROPANEDIOL;2,4,6-Tri-tert-Butylphenyl, 2-butyl, 2-ethyl, 1,3 propandiolphosphit;5-Butyl-5-ethyl-2-(2,4,6-tris(1,1-dimethylethyl) phenoxy)-1,3,2-dioxaphosphorinane;5-butyl-5-ethyl-2-(2,4,6-tritert-butylphenoxy)-1,3,2-dioxaphosphinane
CAS No.161717-32-4

Synthetic Route by SureRoute

1. ACLDSG527 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLDSG527 route product structure diagram
    ACLDSG527161717-32-4
Inquiry

2. ACLDSG527 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLDSG527 route product structure diagram
    ACLDSG527161717-32-4
Inquiry

Comments (0)